CTRI/2021/06/034087尚未招募4 期
long term results comparing concurrent chemoradiotherapy with concomitant boost radiotherapy in locally addvanced head and neck cancer.
Indira Gandhi Medical College Shimla0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Histology â?? squamous cell carcinoma.17
- •Stage III, IV A and IV B.
- •Previously untreated patients.
- •Hb > 10gm%.
- •Pre-treated leucocyte count of > 4000/cu mm.
- •Platelet count > 100,000/cu mm.
- •Normal renal and liver function tests.
- •Karnofsky performance status αα>= 70.
排除标准
- •Histology other than squamous cell carcinoma.
- •Sites other than oropharynx, hypopharynx, and larynx.
- •Age > 70yrs.
- •Deranged RFT / LFT.
- •Previous treatment with RT/ Chemotherapy.
- •Any prior/ synchronous malignancy.
- •Hypersensitivity to platinum agents.
- •Lymph nodes extending behind the spinal cord.
- •Karnofsky performance status < 70.
- •Distant metastasis
研究者
相似试验
已完成
2 期
CCRT for Esophageal Cancer.Concurrent ChemoradiotherapyOxaliplatinPaclitaxelEsophageal CancerNCT02607982Hangzhou Cancer Hospital34
Unknown
3 期
A comparison of concurrent chemo-radiotherapy plus hyperthermia versus concurrent chemo-radiotherapy in locally advanced cervical cancer patients: A randomized controlled trial-This study aim to compare concurrent chemoradiotherapy and concurrent chemoradiotherapy plus hyperthermia in locally advanced cervical cancer in term of treatment response rate.Deep regional hyperthermiaThermotron-RF8radiation therapychemotherapyTCTR20180711002Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy90
招募中
2 期
The efficacy and safety of concurrent chemoradiotherapy for squamous cell carcinoma of the vulva. Phase II StudyVulva cancerJPRN-UMIN000013439TGCU(Tohoku Gynecological Cancer Unit)40
尚未招募
2 期
comparison of 2 schedules of chemotherapy in concurrent chemoradiation in head and neck cancerCTRI/2013/05/003703Regional Cancer CentreTrivandrum100
已完成
2 期
Comparison of 3-weekly administration of continuous dose cisplatin with divided dose in head and neck carcinomaIRCT20201220049776N1Tehran University of Medical Sciences60